Bshra Ali A Alsfouk (Bshra A Alsfouk)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Molecular Dynamics Simulations

Acute Respiratory Distress Syndrome

Newly Diagnosed

Top Venues

Molecules (Basel, Switzerland)

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed A Abdelkader, Bshra Ali A Alsfouk, Asmaa Saleh, Mohamed E A Abdelrahim, Haitham Saeed
Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome. Pharmaceutics 16 (7) (2024)
Ahmed A Abdelkader, Bshra Ali A Alsfouk, Asmaa Saleh, Mohamed E A Abdelrahim, Haitham Saeed
Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome. Pharmaceutics 16 (7) (2024)
Ahmed A Abdelkader, Bshra Ali A Alsfouk, Asmaa Saleh, Mohamed E A Abdelrahim, Haitham Saeed
Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome. Pharmaceutics 16 (7) (2024)
Souad A El-Metwally, Hazem Elkady, Muhammad A Hagras, Eslam B Elkaeed, Bshra Ali A Alsfouk, Ahmed S Doghish, Ibrahim M Ibrahim, Mohammed S Taghour, Dalal Z Husein, Ahmed M Metwaly, Ibrahim H Eissa
Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3- d ]pyrimidine. Future medicinal chemistry (2023)
Haris Hakeem, Bshra Ali A Alsfouk, Patrick Kwan, Martin J Brodie, Zhibin Chen MBiostat
Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30-year cohort study. Epilepsia (2023)
Ibrahim H Eissa, Reda G Yousef, Hazem Elkady, Aisha A Alsfouk, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life (Basel, Switzerland) 13 (1) (2023)
Hazem A Mahdy, Hazem Elkady, Mohammed S Taghour, Elwan Alaa, Mohammed A Dahab, Mohamed A Elkady, Elsayed Ge Elsakka, Eslam B Elkaeed, Bshra Ali A Alsfouk, Ibrahim M Ibrahim, Ibrahim H Eissa, Ahmed M Metwaly
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations. Future medicinal chemistry (2023)
Haris Hakeem, Bshra Ali A Alsfouk, Patrick Kwan, Martin J Brodie, Zhibin Chen MBiostat
Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30-year cohort study. Epilepsia (2023)
Ibrahim H Eissa, Reda G Yousef, Hazem Elkady, Aisha A Alsfouk, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life (Basel, Switzerland) 13 (1) (2023)
Ibrahim H Eissa, Reda G Yousef, Hazem Elkady, Aisha A Alsfouk, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life (Basel, Switzerland) 13 (1) (2023)
Aisha A Alsfouk, Hanan M Alshibl, Najla A Altwaijry, Ashwag S Alanazi, Omkulthom Al Kamaly, Ahlam Sultan, Bshra Ali A Alsfouk
New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Ibrahim H Eissa, Reda G Yousef, Hazem Elkady, Aisha A Alsfouk, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life (Basel, Switzerland) 13 (1) (2023)
Eslam B Elkaeed, Reda G Yousef, Mohamed M Khalifa, Albaraa Ibrahim, Ahmed B M Mehany, Ibraheem M M Gobaara, Bshra Ali A Alsfouk, Wagdy M Eldehna, Ahmed M Metwaly, Ibrahim H Eissa, Mohamed Ayman El-Zahabi
Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. Molecules (Basel, Switzerland) 27 (19) (2022)
Eslam B Elkaeed, Reda G Yousef, Hazem Elkady, Ibraheem M M Gobaara, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects. Molecules (Basel, Switzerland) 27 (14) (2022)
Ahmed M Metwaly, Eslam B Elkaeed, Bshra Ali A Alsfouk, Abdulrahman M Saleh, Ahmad E Mostafa, Ibrahim H Eissa
The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula , against SARS-CoV-2. Plants (Basel, Switzerland) 11 (14) (2022)
Bshra Ali A Alsfouk
Neurodevelopmental outcomes in children exposed prenatally to levetiracetam. Therapeutic advances in drug safety 13 (2022)
Yerlan M Suleimen, Rani A Jose, Raigul N Suleimen, Christoph Arenz, Margarita Yu Ishmuratova, Suzanne Toppet, Wim Dehaen, Bshra Ali A Alsfouk, Eslam B Elkaeed, Ibrahim H Eissa, Ahmed M Metwaly
Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease. Molecules (Basel, Switzerland) 27 (5) (2022)
Reda G Yousef, Wagdy M Eldehna, Elwan Alaa, Abdelaziz S Abdelaziz, Ahmed B M Mehany, Ibraheem M M Gobaara, Bshra Ali A Alsfouk, Eslam B Elkaeed, Ahmed M Metwaly, Ibrahim H Eissa
Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2. Molecules (Basel, Switzerland) 27 (13) (2022)
Ibrahim H Eissa, Mohamed S Alesawy, Abdulrahman M Saleh, Eslam B Elkaeed, Bshra Ali A Alsfouk, Abdul-Aziz M M El-Attar, Ahmed M Metwaly
Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'- o -Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs. Molecules (Basel, Switzerland) 27 (7) (2022)
Aisha A Alsfouk, Hanan M Alshibl, Bshra Ali A Alsfouk, Najla A Altwaijry, Ebtehal S Al-Abdullah
Synthesis and Biological Evaluation of Imadazo[1,2- a ]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Yerlan M Suleimen, Rani A Jose, Gulnur K Mamytbekova, Raigul N Suleimen, Margarita Yu Ishmuratova, Wim Dehaen, Bshra Ali A Alsfouk, Eslam B Elkaeed, Ibrahim H Eissa, Ahmed M Metwaly
Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3- O -(6″- O -acetyl)-Glucoside from Calligonum tetrapterum . Plants (Basel, Switzerland) 11 (15) (2022)
Eslam B Elkaeed, Mohamed M Khalifa, Bshra Ali A Alsfouk, Aisha A Alsfouk, Abdul-Aziz M M El-Attar, Ibrahim H Eissa, Ahmed M Metwaly
The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach. Metabolites 12 (11) (2022)
Najla Altwaijry, Alnada Ibrahim, Reem Binsuwaidan, Lina I Alnajjar, Bshra Ali A Alsfouk, Raghdah Almutairi
Distance Education During COVID-19 Pandemic: A College of Pharmacy Experience. Risk management and healthcare policy 14 (2021)
Bshra Ali A Alsfouk, Haris Hakeem, Zhibin Chen MBiostat, Matthew Walters, Martin J Brodie, Patrick Kwan
Characteristics and treatment outcomes of newly diagnosed epilepsy in older people: A 30-year longitudinal cohort study. Epilepsia 61 (12) (2020)
Bshra Ali A Alsfouk, Aisha A Alsfouk, Zhibin Chen, Patrick Kwan, Martin J Brodie
Pharmacological outcomes in teenagers with newly diagnosed epilepsy: A 30-year cohort study. Epilepsia 60 (6) (2019)